Baldur Sveinbjørnsson

Baldur Sveinbjørnsson achieved a Dr. Philos degree at the Medical Faculty of University of Tromsø 1998 with a focus on mechanisms and mediators behind immunomodulation of experimental tumors. Since then, Dr. Sveinbjørnsson has gained a broad experience of preclinical oncology at University of Tromsø and Karolinska Institutet Stockholm.

Dr. Sveinbjørnsson has been involved in the research activities of Lytix Biopharma since the beginning and has the last years led the company research activities as Director Scientific Research. Dr. Sveinbjørnsson is also a visiting professor at the University of Tromsø.